ALLMedicine Cardiovascular Risk Management Center

Jun 1st, 2020 - Obesity and cardiovascular risk management is a critical way to reduce healthcare resource pressure.|2020|Chen L,Hao G,|

May 14th, 2020 - Repurposing Available Anti-inflammatory and Immunomodulating Agents for Cardiovascular Risk Management: A Call for Submissions to Current Clinical Pharmacology.|2020|Mangoni AA,Erre GL,|

May 13th, 2020 - People with diabetes compared with people without exhibit worse prognosis if affected by coronavirus disease 2019 (COVID-19) induced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), particularly when compromising metabolic cont...

Apr 10th, 2020 - Self-home blood pressure (BP) monitoring is recommended to guide clinical decisions on hypertension and is used worldwide for cardiovascular risk management. People usually make their own decisions when purchasing BP devices, which can be made onl...

Feb 23rd, 2020 - The aim was to study the different strategies used to implement cardiovascular risk evaluation and management for patients with rheumatoid arthritis (RA) in daily clinical practice. A questionnaire survey was performed among both the members of th...

Nov 25th, 2018 - Despite major therapeutic advances leading to improved outcomes over the past 2 decades, cardiovascular (CV) disease remains the leading cause of morbidity and mortality in patients with type 2 diabetes (T2D) (1). Over that time, the prevalence of.

Nov 9th, 2018 - The recommendations listed in the present guideline are, whenever possible, evidence based. An initial extensive evidence review, which included literature derived from research involving human subjects, published in English, and indexed in MEDLIN.

Dec 31st, 2017 - Atherosclerotic cardiovascular disease (ASCVD)—defined as coronary heart disease, cerebrovascular disease, or peripheral arterial disease presumed to be of atherosclerotic origin—is the leading cause of morbidity and mortality for individuals with.

Sep 4th, 2017 - In 2016, the American College of Cardiology published the first expert consensus decision pathway (ECDP) on the role of non-statin therapies for low-density lipoprotein (LDL)–cholesterol lowering in the management of atherosclerotic cardiovascular.

Sep 23rd, 2009 - To develop evidence-based EULAR recommendations for cardiovascular (CV) risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA). A multidisciplinary expert committee was convened as a t...

Jun 1st, 2020 - Obesity and cardiovascular risk management is a critical way to reduce healthcare resource pressure.|2020|Chen L,Hao G,|

Jun 1st, 2020 - Prazosin Hydrochloride Capsules, USP is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These...

May 25th, 2020 - Lisinopril and Hydrochlorothiazide Tablets is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions....

May 21st, 2020 - Prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These ben...

May 21st, 2020 - Felodipine tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have be...

May 21st, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape' Coronavirus Resource Center. A new article outlines the many ways in which the COVID-19 pandemic necessitates new considerations beyond traditional cardiovascular risk manageme...

Aug 17th, 2018 - Two studies published in the New England Journal of Medicine support managing cardiovascular risk in patients with type 2 diabetes. Also today, spontaneous intracranial hypotension is a triple misnomer, prolonged antimalarial therapy is linked to.

Aug 15th, 2018 - The second study, which included 271,174 patients with T2DM from the Swedish National Diabetes Register and 1,355,870 controls, examined five risk factors: elevated glycated hemoglobin level, elevated low-density lipoprotein cholesterol level, alb.

Apr 23rd, 2014 - WASHINGTON – High-risk patients managed to a target LDL particle number rather than to an LDL cholesterol goal had 25% fewer cardiovascular events over 3 years of follow-up. "These new data add to the growing body of evidence suggesting that [nucl.

Mar 19th, 2012 - Women with both hypothyroidism and inflammatory arthritis have a nearly fourfold greater risk of developing heart disease, compared with controls. The finding adds to "sparse" data on the long-hypothesized association between hypothyroidism and in.